- Natco Pharma files India's first compulsory licence plea
Natco Pharma has applied for the country's first compulsory licence to sell a generic version of Bayer's patented medicine.
03 Aug, 2011, 05.19 AM IST
- Cipla in talks with Centre to share cancer drug know-how
Pharma powerhouse Cipla has started talks with the government to share knowledge on making cancer drugs, which, if successful, could radica...
28 Jun, 2010, 02.52 AM IST
- Cipla makes cancer drug cheaper
Cipla has launched a copycat version of German pharma company Bayer’s cancer medicine Nexavar at one-tenth the price.
09 Apr, 2010, 02.53 AM IST
- HC rejects Bayer plea on Nexavar copycat
The Delhi HC dismissed an appeal by German drugmaker Bayer that sought to stop Cipla from obtaining a marketing approval from the country’s...
10 Feb, 2010, 02.16 AM IST
- Maharashtra wants to keep tabs on healthcare services
Maharashtra may set its foot where almost no state government has ventured so far and where even the Centre fears to tread.
30 Aug, 2006, 03.10 AM IST
- Of patents and pre-grant oppositions
On January 25 this year, the patent office in Chennai rejected a patent application by pharma MNC Novartis for its anti-cancer drug Glivec ...
23 Jun, 2006, 12.09 AM IST